Abstract
Whether enteropathogens were eradicated or persisted in test-of-cure stool cultures from 251 patients with traveler's diarrhea, the durations of diarrhea were similar within the antimicrobial agent-treated (32 versus 33 h) and placebo-treated (82 versus 96 h) groups. Routine test-of-cure stool cultures can be useful for evaluating treatment failures and for assessing asymptomatic carriage of enteropathogens after treatment, but they are not mandated in the design of placebo-controlled antimicrobial treatment trials in traveler's diarrhea when the focus of the trial is clinical efficacy.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anders B. J., Lauer B. A., Paisley J. W., Reller L. B. Double-blind placebo controlled trial of erythromycin for treatment of Campylobacter enteritis. Lancet. 1982 Jan 16;1(8264):131–132. doi: 10.1016/s0140-6736(82)90380-4. [DOI] [PubMed] [Google Scholar]
- DuPont H. L., Ericsson C. D., Galindo E., Wood L. V., Morgan D., Bitsura J. A., Mendiola J. G. Furazolidone versus ampicillin in the treatment of traveler's diarrhea. Antimicrob Agents Chemother. 1984 Aug;26(2):160–163. doi: 10.1128/aac.26.2.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DuPont H. L., Reves R. R., Galindo E., Sullivan P. S., Wood L. V., Mendiola J. G. Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone. N Engl J Med. 1982 Sep 30;307(14):841–844. doi: 10.1056/NEJM198209303071401. [DOI] [PubMed] [Google Scholar]
- Ericsson C. D., DuPont H. L., Sullivan P., Galindo E., Evans D. G., Evans D. J., Jr Bicozamycin, a poorly absorbable antibiotic, effectively treats travelers' diarrhea. Ann Intern Med. 1983 Jan;98(1):20–25. doi: 10.7326/0003-4819-98-1-20. [DOI] [PubMed] [Google Scholar]
- Ericsson C. D., Johnson P. C., DuPont H. L., Morgan D. R. Role of a novel antidiarrheal agent, BW942C, alone or in combination with trimethoprim-sulfamethoxazole in the treatment of traveler's diarrhea. Antimicrob Agents Chemother. 1986 Jun;29(6):1040–1046. doi: 10.1128/aac.29.6.1040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ericsson C. D., Johnson P. C., Dupont H. L., Morgan D. R., Bitsura J. A., de la Cabada F. J. Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial. Ann Intern Med. 1987 Feb;106(2):216–220. doi: 10.7326/0003-4819-106-2-216. [DOI] [PubMed] [Google Scholar]
- Pickering L. K., DuPont H. L., Evans D. G., Evans D. J., Jr, Olarte J. Isolation of enteric pathogens from asymptomatic students from the United States and Latin America. J Infect Dis. 1977 Jun;135(6):1003–1005. doi: 10.1093/infdis/135.6.1003. [DOI] [PubMed] [Google Scholar]
- Pickering L. K., DuPont H. L., Olarte J. Single-dose tetracycline therapy for shigellosis in adults. JAMA. 1978 Feb 27;239(9):853–854. [PubMed] [Google Scholar]
- Pitkanen T., Pettersson T., Pomka A., Kosunen T. U. Effect of erythromycin on the fecal excretion of Campylobacter fetus subspecies jejuni. J Infect Dis. 1982 Jan;145(1):128–128. doi: 10.1093/infdis/145.1.128. [DOI] [PubMed] [Google Scholar]
- Salazar-Lindo E., Sack R. B., Chea-Woo E., Kay B. A., Piscoya Z. A., Leon-Barua R., Yi A. Early treatment with erythromycin of Campylobacter jejuni-associated dysentery in children. J Pediatr. 1986 Aug;109(2):355–360. doi: 10.1016/s0022-3476(86)80404-8. [DOI] [PubMed] [Google Scholar]